Repression of the gene encoding the TGF-β type II receptor is a major target of the EWS-FLI1 oncoprotein

Nature Genetics

Volumn 23, Issue 2, 1999, Pages 222-227

  Hahm, Ki Baik ^a   Cho, Keuna ^a   Lee, Cecile ^a   Im, Young Hyuck ^a   Chang, Jay ^a   Choi, Shin Geon ^a   Sorensen, Poul H B ^b   Thiele, Carol J ^a   Kim, Seong Jin ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b BC CHILDREN S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; ONCOPROTEIN; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; DELETION MUTANT; DNA BINDING; EWING SARCOMA; GENE EXPRESSION REGULATION; GENE FUSION; GENE TRANSLOCATION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; STEM CELL; TUMOR SUPPRESSOR GENE;

ANIMALS; CELL LINE; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; LUCIFERASES; MICE; MICE, NUDE; NEUROBLASTOMA; ONCOGENE PROTEINS, FUSION; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEIN C-FLI-1; PROTO-ONCOGENE PROTEINS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RECOMBINANT FUSION PROTEINS; RNA, MESSENGER; SARCOMA, EWING'S; SEQUENCE DELETION; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0032848660     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/13854     Document Type: Article

References (20)

1. Rabbitts, T.H. Chromosomal translocations in human cancer. Nature 372, 143-149 (1994).
2. Delattre, O. et al. Gene fusion with an ETS DNA binding domain caused by chromosome translocation in human cancers. Nature 359, 162-165 (1992).
3. Sorensen, P.H.B. et al. A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG. Nature Genet. 6, 146-151 (1994).
4. Jeon, I.-S. et al. A variant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1. Oncogene 10, 1229-1234 (1995).
5. May, W. et al. Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation. Proc. Natl Acad. Sci. USA 90, 5752-5756 (1993).
6. Bailly, R.-A. et al. DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma. Mol. Cell. Biol. 14, 3230-3241 (1994).
7. Braun, B.S., Frieden, R., Lessnick, S.L., May, W.A. & Denny, C.T. Identification of target genes for the Ewing's sarcoma EWS-FLI1 fusion protein by representational difference analysis. Mol. Cell. Biol. 15, 4623-4630 (1995).
8. May, W.A. et al. EWS/FLI1-induced manic fringe renders NIH-3T3 cells tumourigenic. Nature Genet. 17, 495-497 (1997).
9. Choi, S.-G. et al. A novel ets-related transcription factor, ERT/ESX/ESE-1, regulates expression of the transforming growth factor-β type II receptor. J. Biol. Chem. 273, 110-117 (1998).
10. Chang, C-H. et al. ESX: a structurally unique Ets overexpressed early during human breast tumourigenesis. Oncogene 14, 1617-1622 (1997).
11. Oettgen, P. et al. Isolation and characterization of a novel epithelial specific transcription factor, ESE-1, a member of the ets family. Mol. Cell. Biol. 17, 4419-4433 (1997).
12. Tymms, M.J. et al. A novel epithelial-expressed ETS gene, ELF3: human and murine cDNA sequences, murine genomic organization, human mapping to 1q32.2 and expression in tissues and cancer. Oncogene 15, 2449-2462 (1997).
13. Andreoli, J.M. et al. The expression of a novel, epithelium-specific ets transcription factor is restricted to the most differentiated layers in the epidermis. Nucleic Acids Res. 25, 4287-4295 (1997).
14. Bae, H.W. et al. Characterization of the promoter region of the human transforming growth factor-β type II receptor gene. J. Biol. Chem. 270, 29460-29468 (1995).
15. Zawel, L. et al. Human Smad3 and Smad4 are sequence-specific transcription activators. Mol. Cell 1, 611-617 (1998).
16. De Alava, E. et al. EWS/FLI1 fusion transcript structure is an independent determinant of progrosis in Ewing's sarcoma. J. Clin. Oncol. 16, 1248-1255 (1998).
17. Thompson, A.D. et al. EAT-2 is a novel SH2 domain containing protein that is up regulated by Ewing's sarcoma EWS/FLI1 fusion gene. Oncogene 15, 2649-2658 (1996).
18. Arvand, A. et al. EWS/FLI1 up regulates mE2-C, a cyclin-selective ubiquitin conjugating enzyme involved in cyclin B destruction. Oncogene 17, 2039-2045.
19. Chang, J. et al. Expression of TGF-β type II receptor reduces tumourigenicity in human gastric cancer cells. Cancer Res. 57, 1-4 (1998).
20. Derynck, R. et al. Human transforming growth factor-β cDNA sequence and expression in tumour cell lines. Nature 316, 701-705 (1985).